These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 3383998

  • 1. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
    Brown NL, Badel MY, Benzoni F, Zanirato J, Vincent JC, Fichelle J, Worcel M.
    Eur J Pharmacol; 1988 Mar 22; 148(1):79-91. PubMed ID: 3383998
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M, Schiavi P, Vincent M, Schmitt H.
    J Cardiovasc Pharmacol; 1984 Mar 22; 6(6):1076-82. PubMed ID: 6084763
    [Abstract] [Full Text] [Related]

  • 3. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA.
    J Pharmacol Exp Ther; 1981 Mar 22; 216(3):552-7. PubMed ID: 6259322
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
    Baum T, Watkins RW, Sybertz EJ, Ahn HS, Nelson S, Coleman W, Tedesco R, Pula KK, Rivelli M, Sabin C.
    Arch Int Pharmacodyn Ther; 1987 Apr 22; 286(2):230-45. PubMed ID: 2884941
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.
    Carr RD, Higgs L, Killingback PG, Nicol AK, O'Connor SE, Robson A, Wells E, Simpson WT.
    Br J Pharmacol; 1990 May 22; 100(1):83-9. PubMed ID: 2164863
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats.
    Chevillard C, Brown NL, Jouquey S, Mathieu MN, Laliberté F, Hamon G.
    J Cardiovasc Pharmacol; 1989 Aug 22; 14(2):297-301. PubMed ID: 2476605
    [Abstract] [Full Text] [Related]

  • 9. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351
    [Abstract] [Full Text] [Related]

  • 10. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O, Bao G, Feelisch M, Unger T, Gohlke P.
    J Pharmacol Exp Ther; 1995 Nov 03; 275(2):854-63. PubMed ID: 7473177
    [Abstract] [Full Text] [Related]

  • 11. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.
    Jouquey S, Stepniewski JP, Hamon G.
    J Cardiovasc Pharmacol; 1994 Nov 03; 23 Suppl 4():S16-8. PubMed ID: 7527096
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys.
    Sybertz EJ, Baum T, Ahn HS, Desiderio DM, Pula KK, Tedesco R, Washington P, Sabin C, Smith E, Becker F.
    Arch Int Pharmacodyn Ther; 1987 Apr 03; 286(2):216-29. PubMed ID: 3036028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats.
    DiNicolantonio R, Doyle AE.
    J Cardiovasc Pharmacol; 1985 Apr 03; 7(5):937-42. PubMed ID: 2413304
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb 03; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J, Koga T, Yamazaki T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1988 Feb 03; 292():203-22. PubMed ID: 3293542
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ, Boucher DM, Cohen DM, Essenburg AD, Major TC, Mertz TE, Olszewski BJ, Randolph AE, Singer RM, Kaplan HR.
    J Pharmacol Exp Ther; 1984 Feb 03; 228(2):312-8. PubMed ID: 6319675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.